<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

 


 

Nordic White HQ-2

   STRATEGY, INVESTMENT AND PARTNERING FOR LIFE SCIENCE EXECUTIVES    


28 -29 August 2019 | Stockholm | Sweden
#LSXNORDIC

DOWNLOAD THE BROCHURE
REGISTER NOW

About the 2nd LSX Nordic Congress

The 2nd LSX Nordic Congress is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.

The Nordic region has long produced world-leading science and innovation and Nasdaq Nordic is one of the leading hubs for biotech companies in Europe, strengthened further by a hugely active IPO market over the last two years. However, growth and venture funding is lacking compared with other hubs and listed Nordic companies face a number of specific challenges in their ongoing funding, growth, development and internationalisation.

With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we will bring together the people that matter to the future of life sciences in the Nordic region to address these challenges and work towards actionable outcomes to help it flourish.

LEARN MORE


Our Event Partners

ABG Sundal Collier
Nasdaq17_313+BK
PWC
Vinge Update



Latest Coverage of our Nordic attendees
5th LSX World Congress, London, 5-6 February 2019 - Coverage from Biostock

 

 2018 Key Speakers

Søren Møller, Managing Partner, Novo Seeds

Søren Møller

Managing Partner
Novo Seeds
Mårten Steen, Partner, HealthCap

Mårten Steen

Partner
HealthCap
Miriam Frieden, Vice President R&D Innovation Sourcing, Novo Nordisk

Miriam Frieden

Vice President R&D Innovation Sourcing
Novo Nordisk
Sten Verland, Senior Partner, Sunstone Capital

Sten Verland

Senior Partner
Sunstone Capital
Mats Blom, CFO, Zealand Pharma

Mats Blom

CFO
Zealand Pharma
Ingrid Teigland Akay, Managing Partner, Hadean Ventures

Ingrid Teigland Akay

Managing Partner
Hadean Ventures
Nina Rawal, Head of Life Science, Industrifonden

Nina Rawal

Head of Life Science
Industrifonden
ÅSA RIISBERG Partner and Head of Healthcare Sector EQT PARTNERS

ÅSA RIISBERG

Partner and Head of Healthcare Sector
EQT PARTNERS
JONAS HANSSON CEO WILSON THERAPEUTICS

JONAS HANSSON

CEO
WILSON THERAPEUTICS
CHRISTINE LIND President & CEO MEDIVIR AB

CHRISTINE LIND

President & CEO
MEDIVIR AB
DON DEBETHIZY Chairman SANIONA

DON DEBETHIZY

Chairman
SANIONA
JENNI NORDBORG National Coordinator Life Sciences GOVERNMENT OFFICES OF SWEDEN

JENNI NORDBORG

National Coordinator Life Sciences
GOVERNMENT OFFICES OF SWEDEN

 

Network

Network

Biotech, medtech and deeptech CxOs will be coming to Stockholm and joined by investors and pharma to address key issues facing their businesses and the wider healthcare sector.

 

Partner

Partner

1-2-1 partnering is a key focus across the two days. Pre-event all attendees and see who is attending, message each other and book meetings to find investors, investment opportunities and connect with potential partners.

 

Learn

Learn

Understand the latest trends, forecasts and insights from leading investors, life science executives, pharma BD&L heads and industry KOLs through presentations and more informal workshops and group discussions.

 

LSXNC19 Features


Never miss an update 

Sign up to event updates to hear about new speakers, promotions, conference news and networking events.